Karen Durell

Associée

Toronto

Disponible en anglais seulement

Bureau

416.595.7913

[email protected]

Ajouter un contact au carnet d'adresses

Secteurs et Expertises

Biographie

ADMISSION AU BARREAU

Ontario, 2008
Alberta, 2001

Formation

D.C.L. (Ph.D.), McGill University
LL.M., McGill University
LL.B., University of Saskatchewan
B.A. (Honours), Queen’s University

Langues

Télécharger le CV

Karen Durell, National Lead, Technology at Miller Thomson, is a seasoned IP lawyer and patent agent. She excels in guiding organizations on IP rights for emerging to established businesses. Karen expertly handles IP procurement, technology transactions, IP audits & due diligence, and technology transfer deals & licenses. Her background in technology and law ensures tailored legal strategies for innovators across various industries.

Her commitment to education is evident through her various teaching roles at McGill University in both law and medicine faculties and her active involvement in delivering insightful presentations on IP issues to diverse audiences through seminars and publications.

Karen’s credentials include being a Member of the Intellectual Property Institute of Canada and a Registered Trademark Agent in Canada and the U.S. Her extensive knowledge and experience make her a trustworthy ally in navigating complex IP landscapes for clients seeking comprehensive legal guidance.

Engagement

Reconnaissance

Registered Patent Agent, Canada, 2004
Registered Trademark Agent, Canada, 2009
Registered Trademark Agent, U.S., 2010

Leadership éclairé

Sessional Lecturer, Patent Agency & Legal Practice Course, McGill University, Faculty of Law
Tutorial Leader, Medical Ethics and Health Law Course, McGill University, Faculty of Medicine
Presenter, “IP Issues in Canada and Canada’s Anti-Spam Laws,” hosted by Clear Law, June 2016
Chapter author, “Vaccines and IP Rights: A Multifaceted Relationship,” in Sunil Thomas, ed., Vaccine Designs–Methods and Protocols (New York: Springer, 2016)
Presenter, “IP Issues in Canada and Canada’s Anti-Spam Laws,” hosted by Lawline, June 2015
Co-presenter with Andrew Sprague
Presenter, “Operating as a Canadian Business Under the New ‘User-Focused’ Copyright Act—MaRS Best Practices” MaRS Best Practices, May, 2013
Co-presenter with Stacey Ivanchuk, “Improving Access to Medicines with a Pharmaceutical Patent Pool: Legal/Business & Antitrust Considerations,” Drug Patents in Canada Conference, hosted by Insight at St. Andrews Club & Conference Centre, 7 May 2010
Editor, “Intellectual Property and Business in Canada,” Business Laws of Canada (Eagan: West (a Thomson Reuters business), 2009-2016).
“Who can Tell the Value of IP?” Recent Developments—Business Law in Canada, Spring/Summer 2009
Co-author with Richard Gold, “Looking Beyond the Firm: Intellectual Asset Management and Biotechnology,” in David Castle, ed., The Role of Intellectual Property Rights in Biotechnology Innovation, (Northampton: Edward Elgar Publishing, 2009).
“IAM & Stakeholder Rights: Can we Tame the ‘Wild West’?” and co-author with Louise Bernier, “Are Gene Patents Really a Threat? Vulnerable Populations and Access to Genetics,” in E. Richard Gold & Bartha Maria Knoppers, eds., Biotechnology IP & Ethics, (Markham: LexisNexis, 2009).
Co-author with Richard Gold, “An All-Asset Approach to Canadian Technology Transfer,” Commissioned Report to Industry Canada, March 2008
Presenter, “BRCA Testing in Canada: The Myth and the Business Model,” Visions National Health Law Conference, hosted by the Health Law Institute, Banff Centre, Banff, Alberta, 9 November 2007
Co-author with Tania Bubela, “Intellectual Property and Biotechnology” in Gad, S.C. ed., Handbook of Pharmaceutical Biotechnology (Cary NC: John Wiley & Sons, 2007)
Presenter, “Open Source Intellectual Property Models: A Forecast,” National Focal Point, Access and Benefit Sharing, Environment Canada at the National Meeting on ABS and Certificates, Gatineau, Quebec, 16 November 2006
“Intellectual property protection for plant derived vaccine technology: here they come are we ready or not?” 10(3) Lex Electronica, 2005
Co-author with E. Richard Gold, “Innovating the Skilled Reader: Tailoring Patents to New Technologies,” 19(1) Intellectual Property Journal 189, 2005
Co-presenter with Richard Gold, “Patent Scope in Genes: A Comparative Analysis of Scope,” Queen Mary Patenting Lives Conference, London, England, 2 December 2005
Co-presenter with Martin Phillipson, “Intellectual Property Rights in agriculture: overview and identification of opportunities for innovation,”Canadian Biotechnology Secretariat, Environment Canada, Genetic Resources in Agriculture: Their role, their governance—implications for Access & Benefit Sharing Conference, Saskatoon, Saskatchewan, 9 November 2005
Co-author with Louise Bernier and E. Richard Gold, “WHO Literature Review on the Impact of Gene Patents on Access to Genetic Technologies and Services: View from Developing Countries,”Background Paper for “Genetics, Genomics and the Patenting of DNA” (2005) LC/NLM QU 33.1, World Health Organization, Geneva, 2004
“Intellectual Property Protection for Computer Software: How Much and What Form is Effective?” 8 International Journal of Law and Information Technology, Oxford University, Press 231, 2000

Adhésions et affiliations

Member, Intellectual Property Institute of Canada

Karen Durell

Secteurs et Expertises

EXPERTISE

Biographie

ADMISSION AU BARREAU

Formation

Langues

Team Heading

Transactions et mandats

Représentation de Northern Commerce Inc., Yellow Pencil Inc. et de NH Labs Inc. en lien avec leur vente à Beringer Capital

Pluribus Technologies Corp. vend POWR Inc, Assured Software Ltd, Rowanwood Professional Services Limited et Cranham Haig Limited

West Coast Machinery Inc. acquiert Shear Power Corp

Perspectives juridiques

Les bureaux de propriété intellectuelle à l’heure de la COVID-19

Engagement

Reconnaissance

Leadership éclairé

Adhésions et affiliations

Partager cette biographie